GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProphotonix Regulatory News (PPIR)

  • There is currently no data for PPIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ProPhotonix Launches COBRAT Cure

28 Jul 2014 07:00

RNS Number : 2934N
ProPhotonix Limited
28 July 2014
 

 

July 28, 2014

 

ProPhotonix Limited

("ProPhotonix" or "the Company")

ProPhotonix Launches COBRA™ Cure for UV Curing, Printing and Machine Vision Markets

Compact, field adjustable, fan-cooled, modular UV LED line light with on board Ethernet control

ProPhotonix Limited (London Stock Exchange - AIM: PPIX and PPIR, OTC: STKR), a designer and manufacturer of LED illumination systems and laser diode modules with operations in Ireland and the United Kingdom, today announces the launch of the COBRA™ Cure, a major upgrade to the power and function of its COBRA Slim Series of Chip-On-Board (COB) LED lighting solutions.

UV COBRA™ Cure is a compact LED line light illuminator with a modular form factor that produces a uniform line up to a peak irradiance of 2 W/cm2. Like its predecessor, UV COBRA Slim, COBRA Cure offers field adjustable optics allowing users to select the optimum lens position for their application in the field. It is available in any length up to 5 meters. Both the COBRA Cure and the COBRA Slim are available in a range of wavelengths including 365nm, 385nm 395nm and 405nm. Multiple wavelength versions are also available.

Commenting on the COBRA Cure launch, Tim Losik, CEO and Chairman of ProPhotonix, said: "We are delighted to launch the Cobra Cure as a new product following successful deployment to a number of lead customers for use in machine vision systems, adhesive curing assembly lines and industrial scale printing applications. Our experienced team of optical, electronic, mechanical and software engineers in combination with our in-house manufacturing capability, worked closely with these customers to deliver the optimum lighting solution for each application."

Losik continued, "We have said on many occasions that we are committed to maintaining and broadening our reputation as innovative solution providers. With the introduction of the COBRA Cure we continue to address wider markets and manufacturers and systems integrators. Standard and Custom UV LED solutions, in addition to our direct emission 405nm laser diode modules available at various power levels, provide a wide range of alternative UV solutions for our customers."

For more information about ProPhotonix' COBRA Cure, visit www.prophotonix.com

Enquiries:

ProPhotonix Limited

Ken Reynolds, Business and Technology Manager

 

sales@prophotonix.com

 

Tel: +1 603 870 8209 / +1 353 21 500 1315

N+1 Singer

Andrew Craig/ Ben Wright

Tel: +44 (0) 207 496 3000

Nominated Adviser and Broker

 

About ProPhotonix

 

ProPhotonix Limited, headquartered in Salem, New Hampshire, is an independent designer and manufacturer of diode-based laser modules and LED systems for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Oclaro, Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUSRRRSNABUUR
12
Date   Source Headline
12th Oct 20123:04 pmRNSDirector/PDMR Shareholding
13th Aug 20127:00 amRNSHalf Yearly Report
9th Aug 20129:53 amRNSGlobal Salesforce Established
25th May 20122:30 pmRNSGrant of Options (Replacement)
24th May 20125:02 pmRNSGrant of Options
17th May 20127:00 amRNSAGM Statement
1st May 20124:21 pmRNSPosting of Annual Report and Accounts
5th Apr 20127:00 amRNSAppointment of Three New Distribution Partners
26th Mar 20127:00 amRNSGrant of Options
19th Mar 20127:00 amRNSAppointment of Joint Broker
1st Mar 20127:00 amRNSFinal Results
1st Feb 20127:00 amRNSChange of Name of Nominated Adviser and Broker
19th Jan 20127:00 amRNSTrading Update and New Product Launch
27th Oct 20117:00 amRNS3rd Quarter Results
2nd Aug 20118:06 amRNSHolding(s) in Company - Replacement
1st Aug 20113:54 pmRNSHolding(s) in Company
28th Jul 20117:00 amRNSHalf Yearly Report
20th Jul 20117:00 amRNSNotice of Results
13th Jul 20117:00 amRNSIssue of Equity
27th May 201110:26 amRNSGrant of Options
26th May 20111:51 pmRNSDirector/PDMR Shareholding
24th May 20115:09 pmRNSDirector/PDMR Shareholding
10th May 20117:00 amRNSChange of Adviser
6th May 201110:20 amRNSDirector's Dealing
4th May 20117:00 amRNS1st Quarter Results
19th Apr 20115:28 pmRNSAnnual Financial Report
29th Mar 201110:46 amRNSGrant of Options
24th Mar 20111:41 pmRNSGrant of Options
15th Mar 20117:00 amRNSDirectorate Change
15th Mar 20117:00 amRNSPreliminary Results
9th Mar 20117:00 amRNSNotice of Results
23rd Dec 20107:00 amRNSFirst Dealings AIM Admission
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.